Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 1768 · Lower Costs for Everyday Americans Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

2 U.S.C. § 901a Enforcement of budget goal

+6 −01 of 2 shown
More for 2 U.S.C. § 901a
Read § 901aOnly this section
2 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in subparagraph (D), by striking such that, and all that follows and inserting such that the payment reduction shall be 2.0 percent.; and

    “such that,” isn't in § 901a(6)(D) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“such that,” not found in /us/usc/t2/s901a/6/D
  2. Carried out:

    by adding at the end the following:(F) On the date on which the President submits the budget under section 1105 of title 31, United States Code, for fiscal year 2033, the President shall order a sequestration of payments for the Medicare programs specified in section 256(d), effective upon issuance, such that, …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 901a(6)–(8)

Start of § 901a to (6)(F) unchanged ·

(i) with respect to the first 5 months in which such order is effective for such fiscal year, the payment reduction shall be 2.0 percent; and

(ii) with respect to the last 7 months in which such order is effective for such fiscal year, the payment reduction shall be 0 percent.

(F) [inserted: On the date on which the President submits the budget under section 1105 of title 31, United States Code, for fiscal year 2033, the President shall order a sequestration of payments for the Medicare programs specified in section 256(d), effective upon issuance, such that, notwithstanding the 2 percent limit specified in subparagraph (A) for such payments—]

(i) [inserted: with respect to the first 2 months in which such order is effective for such fiscal year, the payment reduction shall be 2.0 percent; and]

(ii) [inserted: with respect to the last 10 months in which such order is effective for such fiscal year, the payment reduction shall be 0 percent.]

(7) Adjustment for Medicare If the percentage reduction for the Medicare programs would exceed 2 percent for a fiscal year in the absence of paragraph (6), OMB shall increase the reduction for all other discretionary appropriations and direct spending under paragraph (4) by a uniform percentage to a level sufficient to achieve the reduction required by paragraph (4) in the non-defense function.

(8) Implementation of reductions Any reductions imposed under this section shall be implemented in accordance with section 906(k) of this title.

Rest of § 901a unchanged ·

5 U.S.C. § 5314 Positions at level III

+2 −0Shown
More for 5 U.S.C. § 5314
Read § 5314Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    in section 5314, by adding at the end the following:Under Secretary of Commerce for Communications and Information.; and

§ 5314(111)

Start of § 5314 unchanged ·

Director of the Office of Financial Research.

Director of the National Reconnaissance Office.

Special Counsel of the Office of Special Counsel.

[inserted: Under Secretary of Commerce for Communications and Information.]

6 U.S.C. § 575 Regional emergency communications coordination

+1 −1Shown
More for 6 U.S.C. § 575
Read § 575Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1805(d)(2) of the Homeland Security Act of 2002 (6 U.S.C. 575(d)(2)) is amended by striking Assistant Secretary for Communications and Information of the Department of Commerce and inserting Under Secretary of Commerce for Communications and Information.

§ 575(d)Duties(1)–(4)

Start of § 575 to (d) unchanged ·

(1) assessing the survivability, sustainability, and interoperability of local emergency communications systems to meet the goals of the National Emergency Communications Plan;

(2) reporting annually to the relevant Regional Administrator, the Assistant Director for Emergency Communications, the Chairman of the Federal Communications Commission, and the [struck: Assistant][inserted: Under] Secretary [inserted: of Commerce ]for Communications and Information [struck: of the Department of Commerce ]on the status of its region in building robust and sustainable interoperable voice and data emergency communications networks and, not later than 60 days after the completion of the initial National Emergency Communications Plan under section 572 of this title, on the progress of the region in meeting the goals of such plan;

(3) ensuring a process for the coordination of effective multijurisdictional, multi-agency emergency communications networks for use during natural disasters, acts of terrorism, and other man-made disasters through the expanded use of emergency management and public safety communications mutual aid agreements; and

(4) coordinating the establishment of Federal, State, local, and tribal support services and networks designed to address the immediate and critical human needs in responding to natural disasters, acts of terrorism, and other man-made disasters.

7 U.S.C. § 950bb–6 Federal broadband program coordination

+3 −31 of 2 shown
More for 7 U.S.C. § 950bb–6
Read § 950bb–6Only this section
2 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in subsection (d)(1), in the heading, by striking Assistant secretary and inserting Under secretary; and

    “Assistant secretary” isn't in § 950bb–6(d)(1) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“Assistant secretary” not found in /us/usc/t7/s950bb–6/d/1
  2. Carried out:

    by striking Assistant Secretary each place the term appears and inserting Under Secretary.

§ 950bb–6(a)–(c)

§ 950bb–6. Federal broadband program coordination

(a) Consultation between USDA and NTIA The Secretary shall consult with the [struck: Assistant][inserted: Under] Secretary to assist in the verification of eligibility of the broadband loan and grant programs of the Department of Agriculture. In providing assistance under the preceding sentence, the [struck: Assistant][inserted: Under] Secretary shall make available the broadband assessment and mapping capabilities of the National Telecommunications and Information Administration.

(b) Consultation between USDA and FCC

(1) By USDA The Secretary shall consult with the Commission before providing broadband assistance for a project to serve an area with respect to which another entity is receiving Connect America Fund or Mobility Fund support under the Federal universal service support mechanisms established under section 254 of title 47.

(2) By FCC The Commission shall consult with the Secretary before offering or providing Connect America Fund or Mobility Fund support under the Federal universal service support mechanisms established under section 254 of title 47 to serve an area with respect to which another entity has received broadband assistance under a loan or grant program of the Department of Agriculture.

(c) Report to Congress Not later than 1 year after December 20, 2018, the Secretary, the Commission, and the [struck: Assistant][inserted: Under] Secretary shall submit to the Committee on Agriculture and the Committee on Energy and Commerce of the House of Representatives and the Committee on Agriculture, Nutrition, and Forestry and the Committee on Commerce, Science, and Transportation of the Senate a report on how best to coordinate federally supported broadband programs and activities in order to achieve the following objectives:

(1) Promote high-quality broadband service that meets the long-term needs of rural residents and businesses, by evaluating the broadband service needs in rural areas for each decade through 2050.

(2) Support the long-term viability, sustainability, and utility of federally supported rural broadband infrastructure, by analyzing the technical capabilities of the technologies currently available and reasonably expected to be available by 2035 to meet the broadband service needs of rural residents identified under paragraph (1), including by analyzing the following:

§ 950bb–6(d)Definitions(1)–(3)

(c)(2)(A)–(3)(D) unchanged ·

(d) Definitions In this section:

(1) Assistant Secretary The term “[struck: Assistant][inserted: Under] Secretary” means the [struck: Assistant][inserted: Under] Secretary of Commerce for Communications and Information.

(2) Commission The term “Commission” means the Federal Communications Commission.

(3) Rural area The term “rural area” has the meaning given the term in section 950bb(b)(3) of this title.

15 U.S.C. § 9801 Defined term

+18 −122 of 3 shown
More for 15 U.S.C. § 9801
Read § 9801Only this section
3 changes the bill asks for here, 2 carried out
  1. Carried out:

    by redesignating paragraphs (1) and (2) as subparagraphs (A) and (B), respectively, and adjusting the margins accordingly; and

  2. Not carried out:

    by striking In this title, the term COVID–19 public health emergency— and inserting the following:In this title: (1) COVID–19 public health emergency.— The term COVID–19 public health emergency—; and

    We couldn't carry out this instruction.

    Technical detailthe provision inserted says more than the words struck
  3. Carried out:

    by adding at the end the following:(2) Music tourism.— The term “music tourism” means— (A) the act of traveling to a State or locality to visit historic or modern day music-related attractions, including museums, studios, venues of all sizes, and other sites related to music; or (B) the act of traveling to a …

§ 9801(A)–(2)

§ 9801. Defined term

In this title:1

[struck: (1)] [inserted: (A)] COVID–19 public health emergency The term “COVID–19 public health emergency”—

(A) means the public health emergency first declared on January 31, 2020, by the Secretary of Health and Human Services under section 247d of title 42 with respect to COVID–19; and

(B) includes any renewal of such declaration pursuant to such section 247d of title 42.

[struck: (2)] [inserted: (B)] Music tourism The term “music tourism” means—

(A) the act of traveling to a State or locality to visit historic or modern day music-related attractions, including museums, studios, venues of all sizes, and other sites related to music; or

(B) the act of traveling to a State or locality to attend a music festival, a concert, or other live musical performance or music-related special event.

(2) [inserted: Music tourism.—] [inserted: The term “music tourism” means—]

(A) [inserted: the act of traveling to a State or locality to visit historic or modern day music-related attractions, including museums, studios, venues of all sizes, and other sites related to music; or]

(B) [inserted: the act of traveling to a State or locality to attend a music festival, a concert, or other live musical performance or music-related special event.]

15 U.S.C. § 9803 Responsibilities of the Assistant Secretary of Commerce for Travel and Tourism

+3 −12 of 5 shown
More for 15 U.S.C. § 9803
Read § 9803Only this section
5 changes the bill asks for here, 2 carried out
  1. Not carried out:

    in paragraph (2), by striking ; and and inserting a semicolon;

    “; and” isn't in § 9803(b)(2) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“; and” not found in /us/usc/t15/s9803/b/2
  2. Not carried out:

    in paragraph (3), by striking the period at the end and inserting ; and; and

    The bill strikes “.” at the end of § 9803(b)(3), but the text there doesn't end with it. The law may have changed since the bill was drafted.

    Technical detail“.” is not at the end of /us/usc/t15/s9803/b/3
  3. Not carried out:

    by adding at the end the following:(4) identify locations and events in the United States that are important to music tourism and facilitate and promote domestic travel and tourism to those locations and events..

    The law already reads this way: § 9803(b)(4) is already as the bill would have it.

    Technical detailalready there: /us/usc/t15/s9803/b/4 reads as the bill would have it
  4. Carried out:

    Section 605 of the Visit America Act (15 U.S.C. 9803) is amended by striking subsection (d) and inserting the following:(d) Facilitation of international business and leisure travel.— The Assistant Secretary, in coordination with relevant Federal agencies, shall strive to increase and facilitate international business and leisure travel to the United States and ensure competitiveness by— (1) …

  5. Carried out:

    Section 605(f) of the Visit America Act (15 U.S.C. 9803(f)) is amended by adding at the end the following:(4) Report on goals relating to domestic and international travel.— Not later than 1 year after the date of enactment of the American Music Tourism Act, and every 2 years thereafter, the Assistant Secretary shall submit to the Subcommittee on Tourism, Trade, and Export Promotion …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

1 of the 5 changes this bill asks for here is already in the law as it stands, and was not made a second time. The bill, or another making the same changes, has probably become law since.

§ 9803(c)–(d)

Start of § 9803 to (c)(2) unchanged ·

(3) provide recommendations for policy enhancements and efficiencies; and

(4) provide policy recommendations regarding the gig economy as it relates to travel and tourism.

(d) Facilitation of international business and leisure travel[inserted: .—] The Assistant Secretary, in coordination with relevant Federal agencies, shall strive to increase and facilitate international business and leisure travel to the United States and ensure competitiveness by—

(1) facilitating large meetings, incentives, conferences, and exhibitions in the United States;

§ 9803(f)Reporting requirements(3)–(4)

(d)(2)–(f)(3) unchanged ·

(B) shall include questions in the Survey of International Air Travelers regarding wait-times, visits to public lands, and State data, to the extent applicable.

(4) Report on goals relating to domestic and international travel Not later than 1 year after October 9, 2026, and every 2 years thereafter, the Assistant Secretary shall submit to the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Energy and Commerce of the House of Representatives a report of activities, findings, achievements, and vulnerabilities relating to the goals described in subsections (a) through (d).

(4) [inserted: Report on goals relating to domestic and international travel.—] [inserted: Not later than 1 year after the date of enactment of the American Music Tourism Act, and every 2 years thereafter, the Assistant Secretary shall submit to the Subcommittee on Tourism, Trade, and Export Promotion of the Committee on Commerce, Science, and Transportation of the Senate and the Subcommittee on Innovation, Data, and Commerce of the Committee on Energy and Commerce of the House of Representatives a report of activities, findings, achievements, and vulnerabilities relating to the goals described in subsections (a) through (d).]

17 U.S.C. § 1201 Circumvention of copyright protection systems

+1 −1Shown
More for 17 U.S.C. § 1201
Read § 1201Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1201(a)(1)(C) of title 17, United States Code, is amended by striking Assistant Secretary for Communications and Information of the Department of Commerce and inserting Under Secretary of Commerce for Communications and Information.

§ 1201(a)(1)(B)–(C)

Start of § 1201 to (a)(1)(A) unchanged ·

(B) The prohibition contained in subparagraph (A) shall not apply to persons who are users of a copyrighted work which is in a particular class of works, if such persons are, or are likely to be in the succeeding 3-year period, adversely affected by virtue of such prohibition in their ability to make noninfringing uses of that particular class of works under this title, as determined under subparagraph (C).

(C) During the 2-year period described in subparagraph (A), and during each succeeding 3-year period, the Librarian of Congress, upon the recommendation of the Register of Copyrights, who shall consult with the [struck: Assistant][inserted: Under] Secretary [inserted: of Commerce ]for Communications and Information [struck: of the Department of Commerce ]and report and comment on his or her views in making such recommendation, shall make the determination in a rulemaking proceeding for purposes of subparagraph (B) of whether persons who are users of a copyrighted work are, or are likely to be in the succeeding 3-year period, adversely affected by the prohibition under subparagraph (A) in their ability to make noninfringing uses under this title of a particular class of copyrighted works. In conducting such rulemaking, the Librarian shall examine—

(i) the availability for use of copyrighted works;

(ii) the availability for use of works for nonprofit archival, preservation, and educational purposes;

Rest of § 1201 unchanged ·

21 U.S.C. § 355 New drugs

+19 −0Shown
More for 21 U.S.C. § 355
Read § 355Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 505(j)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(3)) is amended by adding at the end the following:(H) (i) Upon request (in controlled correspondence or an analogous process) by a person that has submitted or intends to submit an abbreviated application under this subsection for a drug that is required by regulation to contain one or more of the same inactive ingredients in …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 355(j)Abbreviated new drug applications(3)–(4)

Start of § 355 to (j)(3)(H)(iii)(II) unchanged ·

(iv) If the Secretary makes a written determination described in clause (iii)(II), the Secretary shall provide notice and a copy of the written determination to the person making the request under clause (i).

(v) The disclosures authorized under clauses (i) and (ii) are disclosures authorized by law, including for purposes of section 1905 of title 18. This subparagraph shall not otherwise be construed to authorize the disclosure of nonpublic qualitative or quantitative information about the ingredients in a listed drug, or to affect the status, if any, of such information as trade secret or confidential commercial information for purposes of section 331(j) of this title, section 552 of title 5, or section 1905 of title 18.

(H)

(i) [inserted: Upon request (in controlled correspondence or an analogous process) by a person that has submitted or intends to submit an abbreviated application under this subsection for a drug that is required by regulation to contain one or more of the same inactive ingredients in the same concentrations as the listed drug referred to, or for which the Secretary determines there is a scientific justification for an approach that is in vitro, in whole or in part, to be used to demonstrate bioequivalence for a drug if such a drug contains one or more of the same inactive ingredients in the same concentrations as the listed drug referred to, the Secretary shall inform the person whether such drug is qualitatively and quantitatively the same as the listed drug. The Secretary may also provide such information to such a person on the Secretary’s own initiative during the review of an abbreviated application under this subsection for such drug.]

(ii) [inserted: Notwithstanding section 301(j), if the Secretary determines that such drug is not qualitatively or quantitatively the same as the listed drug, the Secretary shall identify and disclose to the person—]

(I) [inserted: the ingredient or ingredients that cause such drug not to be qualitatively or quantitatively the same as the listed drug; and]

(II) [inserted: for any ingredient for which there is an identified quantitative deviation, the amount of such deviation.]

(iii) [inserted: If the Secretary determines that such drug is qualitatively and quantitatively the same as the listed drug, the Secretary shall not change or rescind such determination after the submission of an abbreviated application for such drug under this subsection unless—]

(I) [inserted: the formulation of the listed drug has been changed and the Secretary has determined that the prior listed drug formulation was withdrawn for reasons of safety or effectiveness; or]

(II) [inserted: the Secretary makes a written determination that the prior determination must be changed because an error has been identified.]

(iv) [inserted: If the Secretary makes a written determination described in clause (iii)(II), the Secretary shall provide notice and a copy of the written determination to the person making the request under clause (i).]

(v) [inserted: The disclosures authorized under clauses (i) and (ii) are disclosures authorized by law, including for purposes of section 1905 of title 18, United States Code. This subparagraph shall not otherwise be construed to authorize the disclosure of nonpublic qualitative or quantitative information about the ingredients in a listed drug, or to affect the status, if any, of such information as trade secret or confidential commercial information for purposes of section 301(j) of this Act, section 552 of title 5, United States Code, or section 1905 of title 18, United States Code.]

(4) Subject to paragraph (5), the Secretary shall approve an application for a drug unless the Secretary finds—

(A) the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of the drug are inadequate to assure and preserve its identity, strength, quality, and purity;

Rest of § 355 unchanged ·

21 U.S.C. § 355c Research into pediatric uses for drugs and biological products

+36 −216 of 11 shown
More for 21 U.S.C. § 355c
Read § 355cOnly this section
11 changes the bill asks for here, 6 carried out
  1. Carried out:

    by redesignating subparagraphs (B) and (C) as subparagraphs (C) and (D), respectively; and

    The section already has a provision under this letter or number, so it would have two.

  2. Carried out:

    by striking subparagraph (A) and inserting the following:(A) In general.— For purposes of paragraph (1)(B), the investigation described in this paragraph is a molecularly targeted pediatric cancer investigation of— (i) the drug or biological product for which the application referred to in such paragraph is submitted; or (ii) such …

  3. Carried out:

    Section 505B(e)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355c(e)(1)) is amended by adding at the end the following: The Secretary shall determine whether subparagraph (A) or (B) of subsection (a)(1) applies with respect to an application before the date on which the applicant is required to submit the initial pediatric study plan under paragraph (2)(A)..

  4. Not carried out:

    Section 505B(a)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355c(a)(1)) is amended by adding at the end the following:(C) Rule of construction.— No application that is subject to the requirements of subparagraph (B) shall be subject to the requirements of subparagraph (A), and no application (or supplement to an application) that is subject to the requirements of subparagraph (A) shall be …

    The law already reads this way: § 355c(a)(1)(C) is already as the bill would have it.

    Technical detailalready there: /us/usc/t21/s355c/a/1/C reads as the bill would have it
  5. Not carried out:

    in paragraph (3)(C), as redesignated by paragraph (1)(A) of this subsection, by striking investigations described in this paragraph and inserting investigations referred to in subparagraph (A); and

    “investigations described in this paragraph” isn't in § 355c(a)(3)(C) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“investigations described in this paragraph” not found in /us/usc/t21/s355c/a/3/C
  6. Not carried out:

    in paragraph (3)(D), as redesignated by paragraph (1)(A) of this subsection, by striking the assessments under paragraph (2)(B) and inserting the assessments required under paragraph (1)(A).

    “the assessments under paragraph (2)(B)” isn't in § 355c(a)(3)(D) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“the assessments under paragraph (2)(B)” not found in /us/usc/t21/s355c/a/3/D~2
  7. Carried out:

    in paragraph (1), by striking Beginning 270 and inserting Noncompliance letter.—Beginning 270;

  8. Carried out:

    by striking The drug or and inserting Effect of noncompliance.—The drug or; and

  9. Not carried out:

    by striking (except that the drug or biological product shall not be subject to action under section 303) and inserting (except that the drug or biological product shall be subject to action under section 303 only if such person demonstrated a lack of due diligence in satisfying the applicable requirement); and

    “(except that the drug or biological product shall not be subject to action under section 303)” isn't in § 355c(d)(2) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“(except that the drug or biological product shall not be subject to action under section 303)” not found in /us/usc/t21/s355c/d/2
  10. Carried out:

    by adding at the end the following:(3) Limitation.— The Secretary shall not issue enforcement actions under section 303 for failures under this subsection in the case of a drug or biological product that is no longer marketed..

    The section already has a provision under this letter or number, so it would have two.

  11. Not carried out:

    Section 505B(d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355c(d)), as amended by subsection (a), is further amended by adding at the end the following:(4) Due diligence.— Before the Secretary may conclude that a person failed to submit or otherwise meet a requirement as described in the matter preceding paragraph (1), the Secretary shall— (A) issue a noncompliance letter pursuant to paragraph (1); (B) provide such person with …

    The law already reads this way: § 355c(d)(4) is already as the bill would have it.

    Technical detailalready there: /us/usc/t21/s355c/d/4 reads as the bill would have it

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

2 of the 11 changes this bill asks for here are already in the law as it stands, and were not made a second time. The bill, or another making the same changes, has probably become law since.

§ 355c(a)New drugs and biological products(2)–(4)

Start of § 355c to (a)(2)(B)(ii) unchanged ·

(iii) Information on extrapolation A brief documentation of the scientific data supporting the conclusion under clauses (i) and (ii) shall be included in any pertinent reviews for the application under section 355 of this title or section 262 of title 42.

(3) 1 Molecularly targeted pediatric cancer investigation

(A) In general[inserted: .—] For purposes of paragraph (1)(B), the investigation described in this paragraph is a molecularly targeted pediatric cancer investigation of—

(i) the drug or biological product for which the application referred to in such paragraph is submitted; or

(ii) such drug or biological product used in combination with—

(I) an active ingredient of a drug or biological product—

(aa) for which an approved application under section [struck: 355][inserted: 505](j) under this [struck: title][inserted: Act] or under section [struck: 262][inserted: 351](k) of [struck: title][inserted: the] [struck: 42][inserted: Public] [inserted: Health Service Act ]is in effect; and

(bb) that is determined by the Secretary, after consultation with the applicant, to be part of the standard of care for treating a pediatric cancer; or

(II) an active ingredient of a drug or biological product—

(aa) for which an approved application under section [struck: 355][inserted: 505](b) of this [struck: title][inserted: Act] or section [struck: 262][inserted: 351](a) of [struck: title][inserted: the] [struck: 42][inserted: Public] [inserted: Health Service Act ]to treat an adult cancer is in effect and is held by the same person submitting the application under paragraph (1)(B); and

(bb) that is directed at a molecular target that the Secretary determines to be substantially relevant to the growth or progression of a pediatric cancer.

(B) [inserted: Additional requirements.—]

(i) [inserted: Design of investigation.—] [inserted: A molecularly targeted pediatric cancer investigation referred to in subparagraph (A) shall be designed to yield clinically meaningful pediatric study data that is gathered using appropriate formulations for each age group for which the study is required, regarding dosing, safety, and preliminary efficacy to inform potential pediatric labeling.]

(ii) [inserted: Limitation.—] [inserted: An investigation described in subparagraph (A)(ii) may be required only if the drug or biological product for which the application referred to in paragraph (1)(B) contains either—]

(I) [inserted: a single new active ingredient; or]

(II) [inserted: more than one active ingredient, if an application for the combination of active ingredients has not previously been approved but each active ingredient is in a drug product that has been previously approved to treat an adult cancer.]

(iii) [inserted: Results of already-completed preclinical studies of application drug.—] [inserted: With respect to an investigation required pursuant to paragraph (1)(B), the Secretary may require the results of any completed preclinical studies relevant to the initial pediatric study plan be submitted to the Secretary at the same time that the initial pediatric study plan required under subsection (e)(1) is submitted.]

(iv) [inserted: Rule of construction regarding inactive ingredients.—] [inserted: With respect to a combination of active ingredients referred to in subparagraph (A)(ii), such subparagraph shall not be construed as addressing the use of inactive ingredients with such combination.]

[struck: (B)] [inserted: (C)] Additional requirements

(i) Design of investigation A molecularly targeted pediatric cancer investigation referred to in subparagraph (A) shall be designed to yield clinically meaningful pediatric study data that is gathered using appropriate formulations for each age group for which the study is required, regarding dosing, safety, and preliminary efficacy to inform potential pediatric labeling.

(ii) Limitation An investigation described in subparagraph (A)(ii) may be required only if the drug or biological product for which the application referred to in paragraph (1)(B) contains either—

(I) a single new active ingredient; or

(II) more than one active ingredient, if an application for the combination of active ingredients has not previously been approved but each active ingredient is in a drug product that has been previously approved to treat an adult cancer.

(iii) Results of already-completed preclinical studies of application drug With respect to an investigation required pursuant to paragraph (1)(B), the Secretary may require the results of any completed preclinical studies relevant to the initial pediatric study plan be submitted to the Secretary at the same time that the initial pediatric study plan required under subsection (e)(1) is submitted.

(iv) Rule of construction regarding inactive ingredients With respect to a combination of active ingredients referred to in subparagraph (A)(ii), such subparagraph shall not be construed as addressing the use of inactive ingredients with such combination.

[struck: (C)] [inserted: (D)] Extrapolation of data Paragraph (2)(B) shall apply to investigations referred to in subparagraph (A) to the same extent and in the same manner as paragraph (2)(B) applies with respect to the assessments required under paragraph (1)(A).

(D) Deferrals and waivers Deferrals and waivers under paragraphs (4) and (5) shall apply to investigations described in this paragraph to the same extent and in the same manner as such deferrals and waivers apply with respect to the assessments required under paragraph (1)(A).

(4) Deferral

§ 355c(d)Submission of assessments and reports on the investigation(1)–(2)

(a)(4)(A)–(c)(2) unchanged ·

(d) Submission of assessments and reports on the investigation If a person fails to submit a required assessment described in subsection (a)(2) or the investigation described in subsection (a)(3), fails to meet the applicable requirements in subsection (a)(4), or fails to submit a request for approval of a pediatric formulation described in subsection (a) or (b), in accordance with applicable provisions of subsections (a) and (b), the following shall apply:

(1) Noncompliance letter [inserted: Noncompliance letter.—]Beginning 270 days after July 9, 2012, the Secretary shall issue a non-compliance letter to such person informing them of such failure to submit or meet the requirements of the applicable subsection. Such letter shall require the person to respond in writing within 45 calendar days of issuance of such letter. Such response may include the person’s request for a deferral extension if applicable. Such letter and the person’s written response to such letter shall be made publicly available on the Internet Web site of the Food and Drug Administration 60 calendar days after issuance, with redactions for any trade secrets and confidential commercial information. If the Secretary determines that the letter was issued in error, the requirements of this paragraph shall not apply. The Secretary shall inform the Pediatric Advisory Committee of letters issued under this paragraph and responses to such letters.

(2) Effect of noncompliance [inserted: Effect of noncompliance.—]The drug or biological product that is the subject of an assessment described in subsection (a)(2) or the investigation described in subsection (a)(3), applicable requirements in subsection (a)(4), or request for approval of a pediatric formulation, may be considered misbranded solely because of that failure and subject to relevant enforcement action (except that the drug or biological product shall be subject to action under section 333 of this title only if such person demonstrated a lack of due diligence in satisfying the applicable requirement), but such failure shall not be the basis for a proceeding—

(A) to withdraw approval for a drug under section 355(e) of this title; or

(B) to revoke the license for a biological product under section 262 of title 42.

§ 355c(d)–(e)

(d)(3)–(4) unchanged ·

(B) provide such person with a 45-day period beginning on the date of receipt of such noncompliance letter to respond in writing as set forth in such paragraph; and

(C) after reviewing such written response, determine whether the person demonstrated a lack of due diligence in satisfying such requirement.

(3) [inserted: Limitation.—] [inserted: The Secretary shall not issue enforcement actions under section 303 for failures under this subsection in the case of a drug or biological product that is no longer marketed.]

(e) Pediatric study plans

(1) In general An applicant subject to subsection (a) shall submit to the Secretary an initial pediatric study plan prior to the submission of the assessments described under subsection (a)(2) or the investigation described in subsection (a)(3). The Secretary shall determine whether subparagraph (A) or (B) of subsection (a)(1) applies with respect to an application before the date on which the applicant is required to submit the initial pediatric study plan under paragraph (2)(A).1[inserted: The Secretary shall determine whether subparagraph (A) or (B) of subsection (a)(1) applies with respect to an application before the date on which the applicant is required to submit the initial pediatric study plan under paragraph (2)(A).]

(2) Timing; content; meetings

(A) Timing An applicant shall submit the initial pediatric study plan under paragraph (1)—

Rest of § 355c unchanged ·

21 U.S.C. § 355c–1 Report

+3 −12 of 4 shown
More for 21 U.S.C. § 355c–1
Read § 355c–1Only this section
4 changes the bill asks for here, 2 carried out
  1. Carried out:

    in paragraph (11), by striking the semicolon at the end and inserting , including an evaluation of compliance with deadlines provided for in deferrals and deferral extensions;;

  2. Not carried out:

    in paragraph (15), by striking and at the end;

    The bill strikes “and” at the end of § 355c–1(b)(15), but the text there doesn't end with it. The law may have changed since the bill was drafted.

    Technical detail“and” is not at the end of /us/usc/t21/s355c–1/b/15
  3. Not carried out:

    in paragraph (16), by striking the period at the end and inserting ; and; and

    The bill strikes “.” at the end of § 355c–1(b)(16), but the text there doesn't end with it. The law may have changed since the bill was drafted.

    Technical detail“.” is not at the end of /us/usc/t21/s355c–1/b/16
  4. Carried out:

    by adding at the end the following:(17) a listing of penalties, settlements, or payments under section 303 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353) for failure to comply with requirements under such section 505B, including, for each penalty, settlement, or payment, the name of the drug, the …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 355c–1(b)Contents(10)–(12)

Start of § 355c–1 to (b)(9) unchanged ·

(10) an assessment of the successes of and limitations to studying drugs for rare diseases under such sections 355a and 355c of this title;

(11) an assessment of the impact of the amendments to such section 355c of this title made by the FDA Reauthorization Act of 2017 on pediatric research and labeling of drugs and biological products and pediatric labeling of molecularly targeted drugs and biological products for the treatment of cancer, including an evaluation of compliance with deadlines provided for in deferrals and deferral extensions[inserted: , including an evaluation of compliance with deadlines provided for in deferrals and deferral extensions];

(12) an assessment of the efforts of the Secretary to implement the plan developed under section 505C–1 of the Federal Food, Drug, and Cosmetic Act,1 regarding earlier submission of pediatric studies under sections 355a and 355c of this title and section 262(m) of title 42, including—

(A) the average length of time after the approval of an application under section 355(b)(1) of this title or section 262(a) of title 42 before studies conducted pursuant to such section 355a of this title, 355c of this title, or section 262(m) of title 42 are completed, submitted, and incorporated into labeling;

§ 355c–1(b)–(c)

(b)(12)(B)–(15) unchanged ·

(16) the Secretary’s assessment of the overall impact of the amendments made by section 504 of the FDA Reauthorization Act of 2017 on the conduct and effectiveness of pediatric cancer research and the orphan drug program, as well any subsequent recommendations; and

(17) a listing of penalties, settlements, or payments under section 333 of this title for failure to comply with requirements under such section 355c of this title, including, for each penalty, settlement, or payment, the name of the drug, the sponsor thereof, and the amount of the penalty, settlement, or payment imposed.

(17) [inserted: a listing of penalties, settlements, or payments under section 303 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353) for failure to comply with requirements under such section 505B, including, for each penalty, settlement, or payment, the name of the drug, the sponsor thereof, and the amount of the penalty, settlement, or payment imposed; and]

(c) Stakeholder comment At least 180 days prior to the submission of each report under subsection (a), the Secretary shall consult with representatives of patient groups (including pediatric patient groups), consumer groups, regulated industry, academia, and other interested parties to obtain any recommendations or information relevant to the report including suggestions for modifications that would improve pediatric drug research and pediatric labeling of drugs and biological products.

21 U.S.C. § 360cc Protection for drugs for rare diseases or conditions

+2 −01 of 5 shown
More for 21 U.S.C. § 360cc
Read § 360ccOnly this section

21 U.S.C. § 360ff Priority review to encourage treatments for rare pediatric diseases

+2 −21 of 2 shown
More for 21 U.S.C. § 360ff
Read § 360ffOnly this section

21 U.S.C. § 360bbb–4a Priority review to encourage treatments for agents that present national security threats

+1 −1Shown
More for 21 U.S.C. § 360bbb–4a
Read § 360bbb–4aOnly this section

21 U.S.C. § 829a Delivery of a controlled substance by a pharmacy to an administering practitioner

+1 −1Shown
More for 21 U.S.C. § 829a
Read § 829aOnly this section

26 U.S.C. § 9008 Payments for presidential nominating conventions

+1 −1Shown
More for 26 U.S.C. § 9008
Read § 9008Only this section

29 U.S.C. § 1108 Exemptions from prohibited transactions

+96 −365 of 12 shown
More for 29 U.S.C. § 1108
Read § 1108Only this section

29 U.S.C. § 1132 Civil enforcement

+7 −01 of 3 shown
More for 29 U.S.C. § 1132
Read § 1132Only this section

35 U.S.C. § 271 Infringement of patent

+42 −01 of 2 shown
More for 35 U.S.C. § 271
Read § 271Only this section

41 U.S.C. § 3904 Contract authority for severable services contracts and multiyear contracts

+4 −0Shown
More for 41 U.S.C. § 3904
Read § 3904Only this section

42 U.S.C. § 247b–7 Loan repayment program

+1 −1Shown
More for 42 U.S.C. § 247b–7
Read § 247b–7Only this section

42 U.S.C. § 247b–8 Fellowship and training programs

+5 −1Shown
More for 42 U.S.C. § 247b–8
Read § 247b–8Only this section

42 U.S.C. § 247b–12 Safe motherhood

+23 −183 of 6 shown
More for 42 U.S.C. § 247b–12
Read § 247b–12Only this section

42 U.S.C. § 247b–21 Mosquito-borne diseases; coordination grants to States; assessment and control grants to political subdivisions

+33 −31Shown
More for 42 U.S.C. § 247b–21
Read § 247b–21Only this section

42 U.S.C. § 247d Public health emergencies

+6 −66 of 8 shown
More for 42 U.S.C. § 247d
Read § 247dOnly this section

42 U.S.C. § 247d–1 Vaccine tracking and distribution

+1 −1Shown
More for 42 U.S.C. § 247d–1
Read § 247d–1Only this section

42 U.S.C. § 247d–2 Earlier development of diagnostic tests

+39 −2Shown
More for 42 U.S.C. § 247d–2
Read § 247d–2Only this section

42 U.S.C. § 247d–3a Improving State and local public health security

+10 −1011 of 13 shown
More for 42 U.S.C. § 247d–3a
Read § 247d–3aOnly this section

42 U.S.C. § 247d–3b Partnerships for State and regional hospital preparedness to improve surge capacity

+16 −811 of 13 shown
More for 42 U.S.C. § 247d–3b
Read § 247d–3bOnly this section

42 U.S.C. § 247d–3c Guidelines for regional health care emergency preparedness and response systems

+2 −2Shown
More for 42 U.S.C. § 247d–3c
Read § 247d–3cOnly this section

42 U.S.C. § 247d–4 Facilities and capacities of the Centers for Disease Control and Prevention

+2 −2Shown
More for 42 U.S.C. § 247d–4
Read § 247d–4Only this section

42 U.S.C. § 247d–5 Combating antimicrobial resistance

+146 −130Shown
More for 42 U.S.C. § 247d–5
Read § 247d–5Only this section

42 U.S.C. § 247d–6b Strategic National Stockpile and security countermeasure procurements

+79 −5122 of 24 shown
More for 42 U.S.C. § 247d–6b
Read § 247d–6bOnly this section

42 U.S.C. § 247d–6e Covered countermeasure process

+8 −2Shown
More for 42 U.S.C. § 247d–6e
Read § 247d–6eOnly this section

42 U.S.C. § 247d–7b Emergency system for advance registration of volunteer health professional

+1 −11 of 2 shown
More for 42 U.S.C. § 247d–7b
Read § 247d–7bOnly this section

42 U.S.C. § 247d–7e Biomedical Advanced Research and Development Authority

+10 −6Shown
More for 42 U.S.C. § 247d–7e
Read § 247d–7eOnly this section

42 U.S.C. § 254b–2 Community health centers and the National Health Service Corps Fund

+8 −02 of 6 shown
More for 42 U.S.C. § 254b–2
Read § 254b–2Only this section

42 U.S.C. § 254c–2 Special diabetes programs for type I diabetes

+4 −01 of 3 shown
More for 42 U.S.C. § 254c–2
Read § 254c–2Only this section

42 U.S.C. § 254c–3 Special diabetes programs for Indians

+4 −01 of 3 shown
More for 42 U.S.C. § 254c–3
Read § 254c–3Only this section

42 U.S.C. § 256g Grants for innovative programs

+1 −1Shown
More for 42 U.S.C. § 256g
Read § 256gOnly this section

42 U.S.C. § 256h Program of payments to teaching health centers that operate graduate medical education programs

+10 −01 of 3 shown
More for 42 U.S.C. § 256h
Read § 256hOnly this section

42 U.S.C. § 274 Organ procurement and transplantation network

+29 −01 of 8 shown
More for 42 U.S.C. § 274
Read § 274Only this section

42 U.S.C. § 274f Reimbursement of travel and subsistence expenses incurred toward living organ donation

+32 −204 of 8 shown
More for 42 U.S.C. § 274f
Read § 274fOnly this section

42 U.S.C. § 280b–1c Prevention of traumatic brain injury

+12 −8Shown
More for 42 U.S.C. § 280b–1c
Read § 280b–1cOnly this section

42 U.S.C. § 280b–1d National program for traumatic brain injury surveillance and registries

+7 −77 of 8 shown
More for 42 U.S.C. § 280b–1d
Read § 280b–1dOnly this section

42 U.S.C. § 280b–3 Authorization of appropriations

+1 −11 of 2 shown
More for 42 U.S.C. § 280b–3
Read § 280b–3Only this section

42 U.S.C. § 280g–3 Prescription drug monitoring program

+2 −0Shown
More for 42 U.S.C. § 280g–3
Read § 280g–3Only this section

42 U.S.C. § 284m Program for pediatric studies of drugs

+1 −1Shown
More for 42 U.S.C. § 284m
Read § 284mOnly this section

42 U.S.C. § 290bb–7a Youth prevention and recovery

+12 −104 of 18 shown
More for 42 U.S.C. § 290bb–7a
Read § 290bb–7aOnly this section

42 U.S.C. § 290bb–36c National Suicide Prevention Lifeline program

+48 −242 of 5 shown
More for 42 U.S.C. § 290bb–36c
Read § 290bb–36cOnly this section

42 U.S.C. § 290ee–2a Peer support technical assistance center

+32 −172 of 4 shown
More for 42 U.S.C. § 290ee–2a
Read § 290ee–2aOnly this section

42 U.S.C. § 290ee–8 Career Act; treatment, recovery, and workforce support grants

+27 −235 of 13 shown
More for 42 U.S.C. § 290ee–8
Read § 290ee–8Only this section

42 U.S.C. § 290hh–1 Grants to address the problems of persons who experience traumatic events

+17 −154 of 12 shown
More for 42 U.S.C. § 290hh–1
Read § 290hh–1Only this section

42 U.S.C. § 300d–52 State grants for projects regarding traumatic brain injury

+24 −7Shown
More for 42 U.S.C. § 300d–52
Read § 300d–52Only this section

42 U.S.C. § 300d–53 State grants for protection and advocacy services

+1 −1Shown
More for 42 U.S.C. § 300d–53
Read § 300d–53Only this section

42 U.S.C. § 300d–91 Military and civilian partnership for trauma readiness grant program

+1 −1Shown
More for 42 U.S.C. § 300d–91
Read § 300d–91Only this section

42 U.S.C. § 300i–2 Community water system risk and resilience

+4 −4Shown
More for 42 U.S.C. § 300i–2
Read § 300i–2Only this section

42 U.S.C. § 300k Establishment of program of grants to States

+12 −8Shown
More for 42 U.S.C. § 300k
Read § 300kOnly this section

42 U.S.C. § 300m Requirements with respect to type and quality of services

+3 −91Shown
More for 42 U.S.C. § 300m
Read § 300mOnly this section

42 U.S.C. § 300n–4 Evaluations and reports

+2 −22 of 3 shown
More for 42 U.S.C. § 300n–4
Read § 300n–4Only this section

42 U.S.C. § 300n–5 Funding for general program

+1 −11 of 2 shown
More for 42 U.S.C. § 300n–5
Read § 300n–5Only this section

42 U.S.C. § 300aa–11 Petitions for compensation

+4 −23 of 4 shown
More for 42 U.S.C. § 300aa–11
Read § 300aa–11Only this section

42 U.S.C. § 300aa–14 Vaccine Injury Table

+2 −0Shown
More for 42 U.S.C. § 300aa–14
Read § 300aa–14Only this section

42 U.S.C. § 300aa–15 Compensation

+1 −1Shown
More for 42 U.S.C. § 300aa–15
Read § 300aa–15Only this section

42 U.S.C. § 300aa–16 Limitations of actions

+2 −0Shown
More for 42 U.S.C. § 300aa–16
Read § 300aa–16Only this section

42 U.S.C. § 300gg–22 Enforcement

+5 −5Shown
More for 42 U.S.C. § 300gg–22
Read § 300gg–22Only this section

42 U.S.C. § 300hh–1 National Health Security Strategy

+21 −1714 of 15 shown
More for 42 U.S.C. § 300hh–1
Read § 300hh–1Only this section

42 U.S.C. § 300hh–10 Coordination of preparedness for and response to all-hazards public health emergencies

+25 −1919 of 20 shown
More for 42 U.S.C. § 300hh–10
Read § 300hh–10Only this section

42 U.S.C. § 300hh–10a Public Health Emergency Medical Countermeasures Enterprise

+13 −5Shown
More for 42 U.S.C. § 300hh–10a
Read § 300hh–10aOnly this section

42 U.S.C. § 300hh–10b National Advisory Committee on Children and Disasters

+5 −2Shown
More for 42 U.S.C. § 300hh–10b
Read § 300hh–10bOnly this section

42 U.S.C. § 300hh–10c National Advisory Committee on Seniors and Disasters

+11 −105 of 7 shown
More for 42 U.S.C. § 300hh–10c
Read § 300hh–10cOnly this section

42 U.S.C. § 300hh–10d National Advisory Committee on Individuals With Disabilities and Disasters

+37 −427 of 10 shown
More for 42 U.S.C. § 300hh–10d
Read § 300hh–10dOnly this section

42 U.S.C. § 300hh–11 National Disaster Medical System

+1 −11 of 2 shown
More for 42 U.S.C. § 300hh–11
Read § 300hh–11Only this section

42 U.S.C. § 300hh–15 Volunteer Medical Reserve Corps

+1 −1Shown
More for 42 U.S.C. § 300hh–15
Read § 300hh–15Only this section

42 U.S.C. § 300hh–31 Epidemiology-laboratory capacity grants

+1 −1Shown
More for 42 U.S.C. § 300hh–31
Read § 300hh–31Only this section

42 U.S.C. § 300mm–61 World Trade Center Health Program Fund

+20 −102 of 3 shown
More for 42 U.S.C. § 300mm–61
Read § 300mm–61Only this section

42 U.S.C. § 710 Sexual risk avoidance education

+2 −23 of 8 shown
More for 42 U.S.C. § 710
Read § 710Only this section

42 U.S.C. § 713 Personal responsibility education

+3 −35 of 10 shown
More for 42 U.S.C. § 713
Read § 713Only this section

42 U.S.C. § 1395f Conditions of and limitations on payment for services

+1 −11 of 5 shown
More for 42 U.S.C. § 1395f
Read § 1395fOnly this section

42 U.S.C. § 1395l Payment of benefits

+23 −68 of 12 shown
More for 42 U.S.C. § 1395l
Read § 1395lOnly this section

42 U.S.C. § 1395m Special payment rules for particular items and services

+55 −37 of 18 shown
More for 42 U.S.C. § 1395m
Read § 1395mOnly this section

42 U.S.C. § 1395w–4 Payment for physicians’ services

+4 −23 of 6 shown
More for 42 U.S.C. § 1395w–4
Read § 1395w–4Only this section

42 U.S.C. § 1395w–21 Eligibility, election, and enrollment

+2 −0Shown
More for 42 U.S.C. § 1395w–21
Read § 1395w–21Only this section

42 U.S.C. § 1395w–22 Benefits and beneficiary protections

+36 −03 of 7 shown
More for 42 U.S.C. § 1395w–22
Read § 1395w–22Only this section

42 U.S.C. § 1395w–27 Contracts with Medicare+Choice organizations

+28 −25 of 8 shown
More for 42 U.S.C. § 1395w–27
Read § 1395w–27Only this section

42 U.S.C. § 1395w–104 Beneficiary protections for qualified prescription drug coverage

+45 −9Shown
More for 42 U.S.C. § 1395w–104
Read § 1395w–104Only this section

42 U.S.C. § 1395w–112 Requirements for and contracts with prescription drug plan (PDP) sponsors

+222 −0Shown
More for 42 U.S.C. § 1395w–112
Read § 1395w–112Only this section

42 U.S.C. § 1395w–114 Premium and cost-sharing subsidies for low-income individuals

+1 −11 of 2 shown
More for 42 U.S.C. § 1395w–114
Read § 1395w–114Only this section

42 U.S.C. § 1395w–152 Miscellaneous provisions

+53 −0Shown
More for 42 U.S.C. § 1395w–152
Read § 1395w–152Only this section

42 U.S.C. § 1395x Definitions

+21 −23 of 6 shown
More for 42 U.S.C. § 1395x
Read § 1395xOnly this section

42 U.S.C. § 1395cc–7 Extension of Acute Hospital Care at Home initiative

+62 −378 of 10 shown
More for 42 U.S.C. § 1395cc–7
Read § 1395cc–7Only this section

42 U.S.C. § 1396a State plans for medical assistance

+93 −111 of 17 shown
More for 42 U.S.C. § 1396a
Read § 1396aOnly this section

42 U.S.C. § 1396b Payment to States

+3 −1Shown
More for 42 U.S.C. § 1396b
Read § 1396bOnly this section

42 U.S.C. § 1396n Compliance with State plan and payment provisions

+79 −38 of 10 shown
More for 42 U.S.C. § 1396n
Read § 1396nOnly this section

42 U.S.C. § 1396r–4 Adjustment in payment for inpatient hospital services furnished by disproportionate share hospitals

+5 −35 of 16 shown
More for 42 U.S.C. § 1396r–4
Read § 1396r–4Only this section

42 U.S.C. § 1396r–8 Payment for covered outpatient drugs

+58 −810 of 15 shown
More for 42 U.S.C. § 1396r–8
Read § 1396r–8Only this section

42 U.S.C. § 1396u–2 Provisions relating to managed care

+2 −0Shown
More for 42 U.S.C. § 1396u–2
Read § 1396u–2Only this section

42 U.S.C. § 1397gg Strategic objectives and performance goals; plan administration

+31 −29Shown
More for 42 U.S.C. § 1397gg
Read § 1397ggOnly this section

42 U.S.C. § 6627 Federally-funded research with enhanced pathogens of pandemic potential

+21 −9Shown
More for 42 U.S.C. § 6627
Read § 6627Only this section

42 U.S.C. § 7545 Regulation of fuels

+38 −47 of 11 shown
More for 42 U.S.C. § 7545
Read § 7545Only this section

42 U.S.C. § 16137 Authorization of appropriations

+1 −1Shown
More for 42 U.S.C. § 16137
Read § 16137Only this section

47 U.S.C. § 223 Obscene or harassing telephone calls in the District of Columbia or in interstate or foreign communications

+298 −1552 of 4 shown
More for 47 U.S.C. § 223
Read § 223Only this section

47 U.S.C. § 254 Universal service

+22 −0Shown
More for 47 U.S.C. § 254
Read § 254Only this section

47 U.S.C. § 763d Encouraging market access and privatization

+1 −1Shown
More for 47 U.S.C. § 763d
Read § 763dOnly this section

47 U.S.C. § 902 Establishment; assigned functions

+10 −2Shown
More for 47 U.S.C. § 902
Read § 902Only this section

47 U.S.C. § 904 General administrative provisions

+8 −43 of 5 shown
More for 47 U.S.C. § 904
Read § 904Only this section

47 U.S.C. § 906 Wireless supply chain innovation and multilateral security

+6 −61 of 2 shown
More for 47 U.S.C. § 906
Read § 906Only this section

47 U.S.C. § 1205 Funding

+2 −21 of 2 shown
More for 47 U.S.C. § 1205
Read § 1205Only this section

47 U.S.C. § 1305 Broadband Technology Opportunities Program

+23 −25Shown
More for 47 U.S.C. § 1305
Read § 1305Only this section

47 U.S.C. § 1306 Connecting minority communities

+1 −1Shown
More for 47 U.S.C. § 1306
Read § 1306Only this section

47 U.S.C. § 1307 Office of Internet Connectivity and Growth

+2 −22 of 3 shown
More for 47 U.S.C. § 1307
Read § 1307Only this section

47 U.S.C. § 1401 Definitions

+96 −96Shown
More for 47 U.S.C. § 1401
Read § 1401Only this section

47 U.S.C. § 1607 NTIA program for preventing future vulnerabilities

+4 −41 of 2 shown
More for 47 U.S.C. § 1607
Read § 1607Only this section

47 U.S.C. § 1725 Policy research, data collection, analysis and modeling, evaluation, and dissemination

+1 −12 of 3 shown
More for 47 U.S.C. § 1725
Read § 1725Only this section

51 U.S.C. § 50112 Promotion of United States Global Positioning System standards

+1 −1Shown
More for 51 U.S.C. § 50112
Read § 50112Only this section

5 U.S.C. § 5315 Positions at level IV

Couldn't place the change
More for 5 U.S.C. § 5315
Read § 5315Only this section

18 U.S.C. § 3014 Additional special assessment

Couldn't place the change
More for 18 U.S.C. § 3014
Read § 3014Only this section

21 U.S.C. § 333 Penalties

Couldn't place the change
More for 21 U.S.C. § 333
Read § 333Only this section

21 U.S.C. § 823 Registration requirements

Couldn't place 11 changes
More for 21 U.S.C. § 823
Read § 823Only this section

26 U.S.C. § 223 Health savings accounts

Couldn't place the change
More for 26 U.S.C. § 223
Read § 223Only this section

26 U.S.C. § 4980D Failure to meet certain group health plan requirements

Already in the law
More for 26 U.S.C. § 4980D
Read § 4980DOnly this section

26 U.S.C. § 9831 General exceptions

Already in the law
More for 26 U.S.C. § 9831
Read § 9831Only this section

29 U.S.C. § 1191a Special rules relating to group health plans

Couldn't place the change
More for 29 U.S.C. § 1191a
Read § 1191aOnly this section

29 U.S.C. § 3225a Addressing economic and workforce impacts of the opioid crisis

Couldn't place the change
More for 29 U.S.C. § 3225a
Read § 3225aOnly this section

42 U.S.C. § 247b–4f Research relating to preterm labor and delivery and the care, treatment, and outcomes of preterm and low birthweight infants

Couldn't place the change
More for 42 U.S.C. § 247b–4f
Read § 247b–4fOnly this section

42 U.S.C. § 247b–13 Prenatal and postnatal health

Couldn't place the change
More for 42 U.S.C. § 247b–13
Read § 247b–13Only this section

42 U.S.C. § 247b–15 Surveillance and education regarding infections associated with illicit drug use and other risk factors

Couldn't place the change
More for 42 U.S.C. § 247b–15
Read § 247b–15Only this section

42 U.S.C. § 247d–7f Collaboration and coordination

Couldn't place the change
More for 42 U.S.C. § 247d–7f
Read § 247d–7fOnly this section

42 U.S.C. § 280b–1 Preventing overdoses of controlled substances

1 of 11 shown
More for 42 U.S.C. § 280b–1
Read § 280b–1Only this section

42 U.S.C. § 290bb–1 Residential treatment programs for pregnant and postpartum women

Couldn't place 4 changes
More for 42 U.S.C. § 290bb–1
Read § 290bb–1Only this section

42 U.S.C. § 290ee–1 First responder training

Couldn't place 9 changes
More for 42 U.S.C. § 290ee–1
Read § 290ee–1Only this section

42 U.S.C. § 290ee–2 Building communities of recovery

Couldn't place the change
More for 42 U.S.C. § 290ee–2
Read § 290ee–2Only this section

42 U.S.C. § 290ee–7 Comprehensive opioid recovery centers

Couldn't place 6 changes
More for 42 U.S.C. § 290ee–7
Read § 290ee–7Only this section

42 U.S.C. § 290ll Fellowships

Already in the law
More for 42 U.S.C. § 290ll
Read § 290llOnly this section

42 U.S.C. § 294e–1 Mental and behavioral health education and training grants

Couldn't place the change
More for 42 U.S.C. § 294e–1
Read § 294e–1Only this section

42 U.S.C. § 295h Loan repayment program for substance use disorder treatment workforce

Couldn't place the change
More for 42 U.S.C. § 295h
Read § 295hOnly this section

42 U.S.C. § 300b–5 Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment

Couldn't place 5 changes
More for 42 U.S.C. § 300b–5
Read § 300b–5Only this section

42 U.S.C. § 300aa–12 Court jurisdiction

Couldn't place 2 changes
More for 42 U.S.C. § 300aa–12
Read § 300aa–12Only this section

42 U.S.C. § 300ii Definitions

Couldn't place the change
More for 42 U.S.C. § 300ii
Read § 300iiOnly this section

42 U.S.C. § 300ii–4 Authorization of appropriations

Couldn't place the change
More for 42 U.S.C. § 300ii–4
Read § 300ii–4Only this section

42 U.S.C. § 300mm–62 Supplemental Fund

Couldn't place the change
More for 42 U.S.C. § 300mm–62
Read § 300mm–62Only this section

42 U.S.C. § 300mm–63 Special Fund

Couldn't place the change
More for 42 U.S.C. § 300mm–63
Read § 300mm–63Only this section

42 U.S.C. § 300mm–64 Pentagon/Shanksville Fund

Couldn't place the change
More for 42 U.S.C. § 300mm–64
Read § 300mm–64Only this section

42 U.S.C. § 701 Authorization of appropriations; purposes; definitions

Couldn't place 2 changes
More for 42 U.S.C. § 701
Read § 701Only this section

42 U.S.C. § 1395w–102 Prescription drug benefits

Couldn't place the change
More for 42 U.S.C. § 1395w–102
Read § 1395w–102Only this section

42 U.S.C. § 1395y Exclusions from coverage and medicare as secondary payer

Couldn't place 2 changes
More for 42 U.S.C. § 1395y
Read § 1395yOnly this section

42 U.S.C. § 1395ww Payments to hospitals for inpatient hospital services

Couldn't place 28 changes
More for 42 U.S.C. § 1395ww
Read § 1395wwOnly this section

42 U.S.C. § 1395aaa Contract with a consensus-based entity regarding performance measurement

Couldn't place 3 changes
More for 42 U.S.C. § 1395aaa
Read § 1395aaaOnly this section

42 U.S.C. § 1396d Definitions

Couldn't place the change
More for 42 U.S.C. § 1396d
Read § 1396dOnly this section

42 U.S.C. § 1397bb General contents of State child health plan; eligibility; outreach

Couldn't place the change
More for 42 U.S.C. § 1397bb
Read § 1397bbOnly this section

47 U.S.C. § 344 Repealed. Pub. L. 117–58, div. F, title VI, § 60602(b), Nov. 15, 2021, 135 Stat. 1249

Couldn't place the change
More for 47 U.S.C. § 344
Read § 344Only this section

47 U.S.C. § 1702 Grants for broadband deployment

Couldn't place 4 changes
More for 47 U.S.C. § 1702
Read § 1702Only this section
Step through the changes